42 results
DEF 14A
APGE
Apogee Therapeutics Inc.
24 Apr 24
Definitive proxy
4:15pm
. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company, from January 2020 to September 2022, where he was responsible for furthering … that position, he spent two years serving as BridgeBio’s Senior Vice President, Asset Acquisition, Strategy and Operations, where he was responsible
10-K
EX-31.2
0v9s9ar7
5 Mar 24
Annual report
6:15am
10-K
i1jmiriy5kqd9rt
5 Mar 24
Annual report
6:15am
10-K
EX-31.1
nac3foxj6 dfeovev
5 Mar 24
Annual report
6:15am
10-K
EX-97.1
6ogzxfcn nxe
5 Mar 24
Annual report
6:15am
DRS
5sminwfbflaj4
9 Feb 24
Draft registration statement
12:00am
10-Q
EX-31.2
7xhub0rk4ej iua
28 Aug 23
Quarterly report
8:00am
10-Q
EX-31.1
oy0lff1 ah
28 Aug 23
Quarterly report
8:00am
10-Q
EX-3.2
duj aynn09r1l
28 Aug 23
Quarterly report
8:00am
10-Q
3yapz 4afqn
28 Aug 23
Quarterly report
8:00am
8-K
EX-99.1
j1a2gk3
28 Aug 23
Apogee Highlights Corporate Progress and Reports Second Quarter 2023 Financial Results
7:35am
424B4
cqj 35x8b
17 Jul 23
Prospectus supplement with pricing info
4:08pm